We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

85 hedge funds and large institutions have $69.6M invested in Cytokinetics in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 17

4% less funds holding

Funds holding: 89 → 85 (-4)

31% less capital invested

Capital invested by funds: $101M → $69.6M (-$30.9M)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

35% less call options, than puts

Call options by funds: $561K | Put options by funds: $869K

Holders
85
Holders Change
-4
Holders Change %
-4.49%
% of All Funds
2.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
34
Reduced
17
Closed
13
Calls
$561K
Puts
$869K
Net Calls
-$308K
Net Calls Change
+$699K

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$2.02M
2
SFM
Sphera Funds Management
Israel
+$1.25M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.01M
4
BI
BVF Inc
California
+$882K
5
Millennium Management
Millennium Management
New York
+$840K

Top Sellers

Rank Fund Capital Flow
1
AWG
Alpha Wave Global
New York
-$8.53M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.79M
3
IGIM
I.G. Investment Management
Manitoba, Canada
-$1.36M
4
BIM
Bogle Investment Management
Massachusetts
-$980K
5
DCM
Driehaus Capital Management
Illinois
-$980K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$104K +$144K +34,360 +6,136%
AG
52
Algert Global
California
$102K +$38.6K +9,190 +47%
NFA
53
Nationwide Fund Advisors
Ohio
$95K +$1.98K +471 +2%
AIG
54
American International Group
New York
$79.6K -$71 -17 -0.1%
Nomura Holdings
55
Nomura Holdings
Japan
$70K +$84K +20,000 New
PCM
56
Prelude Capital Management
New York
$68K +$28.1K +6,700 +53%
GMIM
57
General Motors Investment Management
New York
$60K – – –
Tudor Investment Corp
58
Tudor Investment Corp
Connecticut
$50K -$104K -24,741 -63%
ProShare Advisors
59
ProShare Advisors
Maryland
$48K -$12.9K -3,072 -18%
AllianceBernstein
60
AllianceBernstein
Tennessee
$44K – – –
Principal Financial Group
61
Principal Financial Group
Iowa
$40K – – –
State Board of Administration of Florida Retirement System
62
State Board of Administration of Florida Retirement System
Florida
$37K – – –
RFC
63
Russell Frank Company
Washington
$36K +$42.4K +10,100 New
U
64
UBS
Switzerland
$30K +$23.4K +5,562 +186%
Bank of America
65
Bank of America
North Carolina
$24K -$75.1K -17,871 -72%
BG
66
BlackRock Group
United Kingdom
$22K – – –
BJ
67
BlackRock Japan
Japan
$18K – – –
SGAM
68
Smith Group Asset Management
Texas
$18K – – –
Wells Fargo
69
Wells Fargo
California
$16K -$131K -31,110 -87%
Citigroup
70
Citigroup
New York
$16K +$13.5K +3,221 +264%
US Bancorp
71
US Bancorp
Minnesota
$14K +$76 +18 +0.5%
SO
72
STRS Ohio
Ohio
$12K – – –
BNP Paribas Financial Markets
73
BNP Paribas Financial Markets
France
$7.45K +$8.59K +2,045 +2,880%
Fifth Third Bancorp
74
Fifth Third Bancorp
Ohio
$7K – – –
MA
75
MUFG Americas
New York
$6K +$7.1K +1,690 New
1 2
3
4

CYTK Hedge Fund Activity: Q3 2014 in Review

85 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2014, worth a combined $69.6M — down 31% from $101M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CYTK and 9 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 34 added.

The largest buyer was Wasatch Advisors, adding an estimated $2.02M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $8.53M sold.

  • 85 institutional investors held Cytokinetics (CYTK) as of Q3 2014, down from 89 in Q2 2014.
  • Funds reported $69.6M of Cytokinetics stock for Q3 2014, down 31% quarter-over-quarter.
  • 9 funds opened new Cytokinetics positions in Q3 2014 and 13 closed out, a net change of -4 holders.
  • The largest Cytokinetics buyer in Q3 2014 was Wasatch Advisors, an estimated $2.02M added.
  • The largest Cytokinetics seller in Q3 2014 was Alpha Wave Global, an estimated $8.53M sold.

Based on aggregated 13F filings for Q3 2014.